Cleared Traditional

K952741 - TRIGLYCERIDES (GLYCEROL BLANKING) REAGENT SYSTEM

K952741 is an FDA 510(k) clearance for TRIGLYCERIDES (GLYCEROL BLANKING) REAGE..., manufactured by Medical Diagnostic Technologies, Inc.. The device is a Class 1 Chemistry device with product code CDT cleared through the Traditional 510(k) pathway after a 62-day FDA review.

K952741 · Medical Diagnostic Technologies, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1995
Decision
62d
Days
Class 1
Risk

K952741 is an FDA 510(k) clearance for the TRIGLYCERIDES (GLYCEROL BLANKING) REAGENT SYSTEM. Classified as Lipase Hydrolysis/glycerol Kinase Enzyme, Triglycerides (product code CDT), Class I - General Controls.

Submitted by Medical Diagnostic Technologies, Inc. (Ventura, US). The FDA issued a Cleared decision on August 17, 1995 after a review of 62 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1705 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Medical Diagnostic Technologies, Inc. devices

FDA 510(k) Submission Details - K952741

510(k) Number K952741 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 16, 1995
Decision Date August 17, 1995
Days to Decision 62 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
26d faster than avg
Panel avg: 88d · This submission: 62d
Pathway characteristics
Predicate-based equivalence.

CDT Device Classification - Class 1, General Controls

Product Code CDT Lipase Hydrolysis/glycerol Kinase Enzyme, Triglycerides
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1705
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - CDT Lipase Hydrolysis/glycerol Kinase Enzyme, Triglycerides

All 134
Devices cleared under the same product code (CDT) and FDA review panel - the closest regulatory comparables to K952741.
HORIZON DIAGNOSTICS TRIGLYCERIDES-GPO REAGENT
K933722 · Horizon Diagnostics, Inc. · Jun 1996
TRIGLYCERIDES LIQUID STABLE INCORPORATING DYNAMIC STABILISATION TECHNOLOGY
K953971 · Trace America, Inc. · Apr 1996
TRUE TRIGLYCERIDE
K960088 · Diagnostic Chemicals , Ltd. · Apr 1996
TRIGLYCERODES QVET
K942998 · Prisma Systems · Nov 1994
TRIGLYCERIDES
K931891 · Em Diagnostic Systems, Inc. · Aug 1993
TRIGLYCERIDES GPO-PAP
K923508 · Randox Laboratories, Ltd. · Jul 1993